Monoprost®
The First Preservative-Free Prostaglandin in Canada1
Your First Choice in First-Line Treatment
The use of preservatives in the treatment of glaucoma should be avoided due to their detrimental effects on the ocular surface and consequently on their tolerance.
- Monoprost contains latanoprost 50 µg/ml in a preservative-free, single-dose eye drop formulation2
- Latanoprost is a selective prostanoid FP receptor agonist which reduces intraocular pressure (IOP) by increasing the outflow of aqueous humour2
Monoprost is indicated for the reduction of elevated IOP in patients with open angle glaucoma and ocular hypertension. It reduces the risk of ocular surface problems that have been reported to be caused by long-term use of preservative-containing eye drops.3,4
Key Features
- Long-lasting reduction in IOP
- Preservative-free formulation
- One single-dose container holds enough solution for both eyes
- Significantly lower hyperaemia and other symptoms on instillation than Xalatan with non-inferior efficacy3,4
Monoprost has been shown to provide non-inferior IOP control compared to Xalatan, with statistically significantly lower hyperaemia and symptoms on instillation.3
Studies where patients have been switched from preserved latanoprost to Monoprost have demonstrated reductions in the frequency and severity of hyperaemia and other symptoms.4
How to Use
Recommended dosage for adults (including the elderly): one drop in the affected eye(s) once daily. Optimal effect is obtained if Monopost is administered in the evening.
A single-dose contains enough eye drops solution to treat both eyes.
Store below 25°C.
After first opening of the sachet, use the single-dose containers within 7 days.
After first opening of the single-dose container, use immediately and discard after use.
Bringing innovation to practice